HLS Therapeutics Inc
TSX:HLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
HLS Therapeutics Inc
TSX:HLS
|
CA |
|
Visionflex Group Ltd
ASX:VFX
|
AU |
|
C
|
C3is Inc
NASDAQ:CISS
|
GR |
|
Oncolytics Biotech Inc
TSX:ONC
|
CA |
|
Insulet Corp
NASDAQ:PODD
|
US |
|
C
|
Captivision Inc
NASDAQ:CAPT
|
UK |
|
BCE Inc
TSX:BCE
|
CA |
|
O'Reilly Automotive Inc
NASDAQ:ORLY
|
US |
|
S
|
SYSteel Tech Co Ltd
KOSDAQ:365330
|
KR |
|
Nizhnekamskshina PAO
MOEX:NKSH
|
RU |
|
Sarimelati Kencana Tbk PT
IDX:PZZA
|
ID |
|
Dian Swastatika Sentosa Tbk PT
IDX:DSSA
|
ID |
Wall Street
Price Targets
HLS Price Targets Summary
HLS Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
HLS
is 8.27 CAD
with a low forecast of 4.49 CAD and a high forecast of 12.6 CAD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HLS's stock price target?
Price Target
8.27
CAD
According to Wall Street analysts, the average 1-year price target for
HLS
is 8.27 CAD
with a low forecast of 4.49 CAD and a high forecast of 12.6 CAD.
What is HLS Therapeutics Inc's Revenue forecast?
Projected CAGR
6%
For the last 14 years the
compound annual growth rate for
HLS Therapeutics Inc's revenue is
-3%.
The projected
CAGR
for the next 3 years is
6%.
